)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Aethlon Medical (AEMD) investor relations material
Aethlon Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary12 Nov, 2025
Executive summary
Fiscal Q2 2026 results highlighted clinical progress in the Australian oncology trial, with cohort one showing no serious adverse events and cohort two recruitment underway; the Hemopurifier remains the focus for cancer and viral infections, with discontinued trials in India to conserve resources.
Preclinical R&D continues, including Long COVID studies, platelet-derived extracellular vesicle research, and device simplification initiatives, with ongoing collaborations such as with UCSF.
Achieved and maintained Nasdaq compliance through two reverse stock splits and operational discipline.
No pending or threatened legal proceedings reported.
Financial highlights
Operating expenses for Q2 2026 were $1.5 million, a 48% decrease from $2.9 million in the prior year, mainly due to reductions in payroll, G&A, and professional fees.
Net loss for the quarter was $1.49 million, down from $2.81 million year-over-year; six-month net loss was $3.25 million, down from $5.38 million.
Cash and cash equivalents as of September 30, 2025, totaled $5.85 million, up from $5.50 million at March 31, 2025.
Net cash used in operating activities for the six months was $3.37 million, compared to $3.96 million in the prior year.
Net cash provided by financing activities was $3.74 million, down from $5.38 million year-over-year.
Outlook and guidance
Existing cash is not expected to fund operations for twelve months, raising substantial doubt about the ability to continue as a going concern without additional capital; strategic and financing options, including equity offerings, are being evaluated.
Targeting enrollment of one patient per month in the Australian trial, with potential delays due to holidays; clinical trial expenses and rent expected to increase as activities expand.
Additional data from ongoing and future cohorts will inform the design of future efficacy and safety studies, including a potential PMA study.
Next earnings call scheduled for February 2026.
Impact of new strategies on Cohort 2 enrollment
Benefits of simplified Hemopurifier system
Long COVID program: Next steps post-publication
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Aethlon Medical earnings date
Q3 202611 Feb, 2026
Next Aethlon Medical earnings date
Q3 202611 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Aethlon Medical Inc develops medical devices focused on the removal of harmful substances from the blood. The company’s lead product, Hemopurifier, is designed to filter viruses, exosomes, and other pathogenic particles in therapeutic applications. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage